Fetuin-A 742 (C/T) and 766 (C/G) polymorphic sites are associated with increased risk of myocardial infarction in older patients (≥40 years of age)

Molecular Medicine Reports

Volumn 12, Issue 1, 2015, Pages 1356-1362

  Coker Gurkan, Ajda ^a   Coskun, Deniz ^a   Arisan, Elif Damla ^a   Obakan, Pinar ^a   Soylu, Özer ^b   Unsal, Narcin Palavan ^a  

^a ISTANBUL KULTUR UNIVERSITY   (Turkey)

^b MEDICAL PARK HOSPITAL   (Turkey)

Author keywords

Fetuin A; Myocardial infarction; Single nucleotide polymorphisms

Indexed keywords

FETUIN A; FETUIN A 742; FETUIN A 766; UNCLASSIFIED DRUG; AHSG PROTEIN, HUMAN;

ADULT; ALLELE; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; EXON; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; AGE; GENETICS; INFLAMMATION; MIDDLE AGED; PATHOLOGY; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGE FACTORS; ALPHA-2-HS-GLYCOPROTEIN; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84926646433     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2015.3521     Document Type: Article

References (42)

1. Pouleur AC, Barkoudah E, Uno H, et al: Pathogenesis of sudden unexpected death in a clinical trial of patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. Circulation 122: 597-602, 2010.
2. Wang H and Eitzman DT: Acute myocardial infarction leads to acceleration of atherosclerosis. Atherosclerosis 229: 18-22, 2013.
3. Ross R: Atherosclerosis is an inflammatory disease. Am Heart J 138: 419-420, 1999.
4. Hong C, Zhu F, Du D, Pilgram TK, Sicard GA and Bae KT: Coronary artery calcification and risk factors for atherosclerosis in patients with venous thromboembolism. Atherosclerosis 183: 169-174, 2005.
5. McGeachie M, Ramoni RL, Mychaleckyj JC, et al: Integrative predictive model of coronary artery calcification in atherosclerosis. Circulation 120: 2448-2454, 2009.
6. Westenfeld R, Schäfer C, Smeets R, et al: Fetuin-A (AHSG) prevents extraosseous calcification induced by uraemia and phosphate challenge in mice. Nephrol Dial Transplant 22: 1537-1546, 2007.
7. Anderson L and Anderson NG: High resolution two-dimensional electrophoresis of human plasma proteins. Proc Natl Acad Sci USA 74: 5421-5425, 1977.
8. Lee CC, Bowman BH and Yang FM: Human alpha 2-HS-glycoprotein: the A and B chains with a connecting sequence are encoded by a single mRNA transcript. Proc Natl Acad Sci USA 84: 4403-4407, 1987.
9. Jahnen-Dechent W, Schinke T, Trindl A, et al: Cloning and targeted deletion of the mouse fetuin gene. J Biol Chem 272: 31496-31503, 1997.
10. Auberger P, Falquerho L, Contreres JO, et al: Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification and anti-mitogenic activity. Cell 58: 631-640, 1989.
11. Dahlman I, Eriksson P, Kaaman M, et al: alpha2-Heremans-Schmid glycoprotein gene polymorphisms are associated with adipocyte insulin action. Diabetologia 47: 1974-1979, 2004.
12. Lebreton JP, Joisel F, Raoult JP, Lannuzel B, Rogez JP and Humbert G: Serum concentration of human alpha 2 HS glycoprotein during the inflammatory process: evidence that alpha 2 HS glycoprotein is a negative acute-phase reactant. J Clin Invest 64: 1118-1129, 1979.
13. Schafer C, Heiss A, Schwarz A, et al: The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 112: 357-366, 2003.
14. Rizzu P and Baldini A: Three members of the human cystatin gene superfamily, AHSG, HRG and KNG, map within one megabase of genomic DNA at 3q27. Cytogenet Cell Genet 70: 26-28, 1995.
15. Osawa M, Umetsu K, Sato M, et al: Structure of the gene encoding human alpha 2-HS glycoprotein (AHSG). Gene 196: 121-125, 1997.
16. Osawa M, Yuasa I, Kitano T, et al: Haplotype analysis of the human alpha2-HS glycoprotein (fetuin) gene. Ann Hum Genet 65: 27-34, 2001.
17. Stenvinkel P, Pecoits-Filho R, Lindholm B and DialGene C: Gene polymorphism association studies in dialysis: the nutrition-inflammation axis. Semin Dial 18: 322-330, 2005.
18. Weikert C, Stefan N, Schulze MB, et al: Plasma fetuin-A levels and the risk of myocardial infarction and ischemic stroke. Circulation 118: 2555-2562, 2008.
19. Mehrotra R, Westenfeld R, Christenson P, et al: Serum fetuin-A in nondialyzed patients with diabetic nephropathy: relationship with coronary artery calcification. Kidney Int 67: 1070-1077, 2005.
20. Lim P, Collet JP, Moutereau S, et al: Fetuin-A is an independent predictor of death after ST-elevation myocardial infarction. Clin Chem 53: 1835-1840, 2007.
21. Fisher E, Stefan N, Saar K, et al: Association of AHSG gene polymorphisms with fetuin-A plasma levels and cardiovascular diseases in the EPIC-Potsdam study. Circ Cardiovasc Genet 2: 607-613, 2009.
22. Fried LP, Borhani NO, Enright P, et al: The cardiovascular health study: design and rationale. Ann Epidemiol 1:263-276, 1991.
23. Friedewald WT, Levy RI and Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18: 499-502, 1972.
24. Chen W: Rapid isolation of DNA from human peripheral blood. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 14: 141-142, 1992 (In Chinese).
25. Murray CJ and Lopez AD: Evidence-based health policy-lessons from the global burden of disease study. Science 274: 740-743, 1996.
26. Yusuf S, Reddy S, Ounpuu S and Anand S: Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors and impact of urbanization. Circulation 104: 2746-2753, 2001.
27. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H and Kannel WB: Prediction of coronary heart disease using risk factor categories. Circulation 97: 1837-1847, 1998.
28. Maseri A and Fuster V: Is there a vulnerable plaque? Circulation 107: 2068-2071, 2003.
29. Holmes DR Jr, Hartzler GO, Smith HC and Fuster V: Coronary artery thrombosis in patients with unstable angina. Br Heart J 45: 411-416, 1981.
30. Mandelkorn JB, Wolf NM, Singh S, et al: Intracoronary thrombus in nontransmural myocardial infarction and in unstable angina pectoris. Am J Cardiol 52: 1-6, 1983.
31. Ambrose JA, Winters SL, Arora RR, et al: Coronary angiographic morphology in myocardial infarction: a link between the pathogenesis of unstable angina and myocardial infarction. J Am Coll Cardiol 6: 1233-1238, 1985.
32. Doherty TM, Detrano RC, Mautner SL, Mautner GC and Shavelle RM: Coronary calcium: the good, the bad and the uncertain. Am Heart J 137: 806-814, 1999.
33. Shemesh J, Stroh CI, Tenenbaum A, et al: Comparison of coronary calcium in stable angina pectoris and in first acute myocardial infarction utilizing double helical computerized tomography. Am J Cardiol 81: 271-275, 1998.
34. Raggi P, Cooil B, Shaw LJ, et al: Progression of coronary calcium on serial electron beam tomographic scanning is greater in patients with future myocardial infarction. Am J Cardiol 92: 827-829, 2003.
35. Vliegenthart R, Oudkerk M, Song B, Van der Kuip DA, Hofman A and Witteman JC: Coronary calcification detected by electron-beam computed tomography and myocardial infarction. The rotterdam coronary calcification study. Eur Heart J 23: 1596-1603, 2002.
36. Schinke T, Amendt C, Trindl A, Pöpschke O, Müller-Esterl W and Jahnen-Dechent W: The serum protein alpha2-HS glycoprotein/fetuin inhibits apatite formation in vitro and in mineralizing calvaria cells. A possible role in mineralization and calcium homeostasis. J Biol Chem 271: 20789-20796, 1996.
37. Merx MW, Schäfer C, Westenfeld R, et al: Myocardial stiffness, cardiac remodeling and diastolic dysfunction in calcification-prone fetuin-A-deficient mice. J Am Soc Nephrol 16: 3357-3364, 2005.
38. Stefan N, Hennige AM, Staiger H, et al: Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care 29: 853-857, 2006.
39. Ketteler M, Bongartz P, Westenfeld R, et al: Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet 361: 827-833, 2003.
40. Kaden JJ, Reinöhl JO, Blesch B, et al: Systemic and local levels of fetuin-A in calcific aortic valve stenosis. Int J Mol Med 20: 193-197, 2007.
41. Ix JH, Chertow GM, Shlipak MG, Brandenburg VM, Ketteler M and Whooley MA: Association of fetuin-A with mitral annular calcification and aortic stenosis among persons with coronary heart disease: data from the Heart and Soul Study. Circulation 115: 2533-2539, 2007.
42. Afsar CU, Uzun H, Yurdakul S, et al: Association of serum fetuin-A levels with heart valve calcification and other biomarkers of inflammation among persons with acute coronary syndrome. Clin Invest Med 35: E206-E215, 2012.